Nureca Reports Strong Q2 FY27 Growth

Revenue: Rs 585.26 Million | Net Profit: Rs 40.51 Million

Reader Takeaway: Robust top-line expansion drives 11% quarterly profit growth, while NCLT merger approval remains the key structural watchpoint.

What just happened

Nureca Ltd has reported its financial results for the quarter ended September 30, 2026. The company achieved a consolidated revenue of Rs 585.26 million, marking a significant 55% year-on-year increase compared to Rs 377.40 million in the same period last year. Net profit for the quarter rose to Rs 40.51 million, up from Rs 36.26 million in Q2 FY26. For the first half of the fiscal year, revenue reached Rs 988.69 million with a net profit of Rs 71.18 million.

Why this matters

The results highlight successful operational scaling for the healthcare and wellness company. The strong revenue growth indicates steady demand for its product portfolio, while the expansion in net profit reflects improved operational efficiency. The Board approved these results on October 21, 2026, and the statutory auditors have provided an unmodified Limited Review Report.

The backstory

Nureca is currently working toward a merger with its wholly-owned subsidiary, Nureca Technologies Private Limited. The scheme is effective from an appointed date of April 1, 2025. As the NCLT and other regulatory sanctions are still pending, the company has clarified that these current financial results do not incorporate any accounting adjustments related to the merger.

What to track next

Investors should monitor future updates regarding the NCLT sanction for the merger. As the process moves forward, the integration of Nureca Technologies may alter the company's financial structure, which will be reflected in subsequent filings once the merger receives formal regulatory approval.